Our expertise within health economics and evidence synthesis, combined with our experience as HTA assessors, provides us with a unique insight into preparing robust health economic models for submissions.
Our approach includes identifying key areas of uncertainty in economic evidence, suggesting proactive mitigation strategies, and anticipating potential challenges from assessment groups and committees.
We employ a holistic and strategic methodology to demonstrate a product’s value, aiming to capture clinical benefits even in the face of limited clinical evidence. This is particularly crucial in the context of rare diseases, where data is often scarce. Our process involves rigorous qualitative and quantitative validation, ensuring that our economic models generate estimates that align with clinical experience. This level of thoroughness instils confidence in assessment groups and committees, facilitating informed decision-making for our clients.
Our team delivers unparalleled accuracy and quality across all aspects of outcomes research, providing comprehensive support to meet your research needs.
Our health economics and evidence synthesis services include:
- Health economic modelling
- Cost-effectiveness modelling
- Health policy modelling
- Budget impact modelling
- Cost-consequence analysis
- Value communication models
- Modelling review and validation
- Evidence synthesis
- Systematic and targeted literature reviews
- Feasibility studies
- Meta-analyses
- Indirect treatment comparisons
- Statistical analysis of clinical trial data
- Real-world evidence generation for market access
- Burden of illness studies
- Resource utilisation studies
- Chart review and registry planning
- Statistical analysis of real-world data
Get in touch with our team to learn more about our health economics and evidence synthesis services:
Or reach out to us at hello@initiateconsultancy.com.
